By Julie Steenhuysen
CHICAGO (Reuters) – The American Medical Association (AMA) on Tuesday called for a total ban on all e-cigarette and vaping products that are not approved by the U.S. Food and Drug Administration as smoking cessation tools.
The AMA is urging regulators and legislators at the state and local levels to ban the sale and distribution of all e-cigarette and vaping products, and stipulates that those products should only be available by prescription.
The group also called for more study on the use of drug and non-drug treatment strategies to deal with nicotine addiction, and is advocating for diagnostic codes for e-cigarette and vaping associated illnesses, which would help better identify patients with lung injuries associated with vaping.
“The recent lung illness outbreak has alarmed physicians and the broader public health community and shined a light on the fact that we have very little evidence about the short- and long-term health consequences of e-cigarettes and vaping products,” AMA President Dr. Patrice Harris said in a statement.
Some 2,000 people have been sickened and at least 42 have died from vaping-related lung injuries, according to the U.S. Centers for Disease Control and Prevention (CDC). Most of those cases, however, have been linked to vaping THC – the psychoactive substance in marijuana – and not nicotine.
The state of California on Monday sued e-cigarette maker Juul Labs Inc, alleging that the San Francisco company engaged in a “systematic” and “wildly successful” campaign to attract teenagers to its nicotine devices.
More than 27.5% of high school students in the United States use e-cigarettes, up from 20.7 percent in 2018, according to the CDC’s National Youth Tobacco Survey.
At a meeting of the AMA House of Delegates in San Diego, physicians, residents, and medical students voted to adopt policies building on the group’s longtime efforts to prevent another generation from becoming dependent on nicotine.
Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.